Geron Corp (GERN)
3.765
+0.10
(+2.87%)
USD |
NASDAQ |
Nov 18, 16:00
3.765
0.00 (0.00%)
After-Hours: 20:00
Geron Debt to Equity Ratio: 0.2868 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.2868 |
| June 30, 2024 | 0.272 |
| March 31, 2024 | 0.2399 |
| December 31, 2023 | 0.3305 |
| September 30, 2023 | 0.1786 |
| June 30, 2023 | 0.1731 |
| March 31, 2023 | 0.1576 |
| December 31, 2022 | 0.6395 |
| September 30, 2022 | 0.4692 |
| June 30, 2022 | 0.355 |
| March 31, 2022 | 0.5147 |
| December 31, 2021 | 0.3942 |
| September 30, 2021 | 0.2288 |
| June 30, 2021 | 0.1953 |
| March 31, 2021 | 0.1204 |
| December 31, 2020 | 0.114 |
| September 30, 2020 | 0.1026 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
0.6395
Maximum
Dec 2022
0.2386
Average
0.2121
Median
Debt to Equity Ratio Benchmarks
| Emergent BioSolutions Inc | 1.303 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.0461 |
| Theriva Biologics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 444.95M |
| Total Liabilities (Quarterly) | 152.67M |
| Shareholders Equity (Quarterly) | 292.28M |
| Current Ratio | 2.886 |
| Net Debt Paydown Yield | -0.24% |